dolasetron has been researched along with Electrocardiogram QT Prolonged in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cavalli, A; De Ponti, F; Poluzzi, E; Recanatini, M | 1 |
| Benson, C; Brown, R; Couderc, JP; Darpo, B; Dota, C; Ferber, G; Ferry, J; Jarugula, V; Keirns, J; Ortemann-Renon, C; Pham, T; Riley, S; Sarapa, N; Ticktin, M; Zareba, W | 1 |
| Obal, D; Sessler, DI; Yang, D | 1 |
| Janicki, PK; Quraishi, SA; Schuler, GH | 1 |
| Shields, JA | 1 |
1 review(s) available for dolasetron and Electrocardiogram QT Prolonged
| Article | Year |
|---|---|
Heart block and prolonged Q-Tc interval following muscle relaxant reversal: a case report.
Topics: Adjuvants, Anesthesia; Adult; Anesthesia, Inhalation; Anesthesia, Intravenous; Anesthetics, Inhalation; Atropine; Cholinesterase Inhibitors; Desflurane; Dexmedetomidine; Droperidol; Drug Monitoring; Electrocardiography; Female; Gastric Bypass; Heart Block; Humans; Hypnotics and Sedatives; Indoles; Isoflurane; Long QT Syndrome; Muscarinic Antagonists; Neostigmine; Nurse Anesthetists; Obesity, Morbid; Quinolizines; Risk Factors; Serotonin Antagonists | 2008 |
1 trial(s) available for dolasetron and Electrocardiogram QT Prolonged
| Article | Year |
|---|---|
Evaluation of the Effect of 5 QT-Positive Drugs on the JTpeak Interval - An Analysis of ECGs From the IQ-CSRC Study.
Topics: Arrhythmias, Cardiac; Biomarkers; Cetirizine; Drug-Related Side Effects and Adverse Reactions; Electrocardiography; Female; Fluoroquinolones; Healthy Volunteers; Heart Conduction System; Heart Rate; Humans; Indoles; Ion Channels; Long QT Syndrome; Male; Moxifloxacin; Ondansetron; Phenethylamines; Quinine; Quinolizines; Risk Assessment; Sulfonamides | 2020 |
3 other study(ies) available for dolasetron and Electrocardiogram QT Prolonged
| Article | Year |
|---|---|
Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K(+) channel blockers.
Topics: Anti-Arrhythmia Agents; Cation Transport Proteins; Cluster Analysis; Databases, Factual; Ether-A-Go-Go Potassium Channels; Long QT Syndrome; Models, Molecular; Molecular Conformation; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quantitative Structure-Activity Relationship | 2002 |
Perioperative doses of ondansetron or dolasetron do not lengthen the QT interval.
Topics: Aged; Aged, 80 and over; Female; Heart Rate; Humans; Indoles; Long QT Syndrome; Male; Middle Aged; Ondansetron; Postoperative Complications; Postoperative Period; Preoperative Care; Quinolizines; Serotonin 5-HT3 Receptor Antagonists; Young Adult | 2014 |
5 HT(3)-receptor antagonists and cardiac repolarization time in patients expressing a novel genetic target associated with baseline QTc interval abnormalities.
Topics: Adaptor Proteins, Signal Transducing; Adult; Alleles; Databases, Genetic; Electrocardiography; Female; Genotype; Granisetron; Hospitals, University; Humans; Indoles; Long QT Syndrome; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Quinolizines; Retrospective Studies; Serotonin 5-HT3 Receptor Antagonists | 2011 |